Edition:
International

Nivedita Bhattacharjee

India seeks more data for emergency AstraZeneca shot approval

Dec 09 2020

BENGALURU India's drugs regulator said https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/common_download.jsp?num_id_pk=MTI3NQ== on Wednesday it had sought more data to make a decision on emergency authorisation for AstraZeneca's COVID-19 vaccine candidate and one developed locally by Bharat Biotech and the government.

India speeding up review of Pfizer, AstraZeneca COVID-19 vaccines: senior official

Dec 07 2020

NEW DELHI/BENGALURU India is accelerating its review of COVID-19 vaccines developed by Pfizer Inc and AstraZeneca to authorise for emergency use, a senior official said on Monday, as the world's second-hardest hit country seeks to contain the virus outbreak.

Google defers Indian in-app fees after angry startups complain

Oct 05 2020

NEW DELHI/BENGALURU Alphabet Inc's Google has extended its deadline for Indian app developers to comply with a new billing system for commission fees by six months, it said on Monday, days after local startups voiced anger about the charges.

India's coronavirus infections spike again after dip

Sep 23 2020

NEW DELHI/BENGALURU, India India's coronavirus infections surged again on Wednesday, a day after falling to their lowest figure in almost a month.

Exclusive: Walmart's Flipkart eyes overseas listing as early as 2021: sources

Sep 16 2020

NEW DELHI/BENGALURU Walmart Inc-controlled Indian e-commerce firm Flipkart is preparing for an initial public offering overseas as early as 2021, which could value the firm up to $50 billion, sources familiar with the company's plans told Reuters.

How India's Silicon Valley saw its COVID-19 success come undone

Aug 25 2020

By Sachin Ravikumar, Derek Francis and Nivedita Bhattacharjee

World News